When bacteria cells replicate, they do so a little differently than human cells do. They don't undergo mitosis, a splitting that involves construction of spindles to carefully separate the DNA after ...
Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.
"If it ain't broke, don't fix it," goes the old adage, which Rice University professor James Chappell completely ignored in a recent Nature Communications publication. In the study, Chappell describes ...
A mitochondrial enzyme, Ak4, strengthens immune defense by promoting mitochondrial DNA synthesis and enhancing macrophage ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial ...
A new flu treatment could drastically reduce one of flu's deadliest complications—bacterial pneumonia—by helping the lungs ...
Acurx Pharma’s DNA Polymerase IIIC inhibitors receives Korean patent: Staten Island, New York Tuesday, March 31, 2026, 17:00 Hrs [IST] Acurx Pharmaceuticals, Inc., a late-stage ...
Rival viruses can eavesdrop on each other’s chemical signals, sometimes triggering the wrong response and changing how ...
Flea-borne typhus cases are rising in Los Angeles, with officials warning residents to take precautions amid growing risks ...
Scientists used a bacterial system called retron to turn DNA into a programmable tool inside living cells, enabling gene ...
The responding phage enters lysogeny prematurely, sparing the bacterial host and reducing competition for the signaling phage ...
Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results